about
Purinergic Receptors: Key Mediators of HIV-1 Infection and InflammationCardiovascular Complications of HIV-Associated Immune DysfunctionIncreased prevalence and severity of radiographic hand osteoarthritis in patients with HIV-1 infection associated with metabolic syndrome: data from the cross-sectional METAFIB-OA study.Antiretroviral treatment outcomes amongst older adults in a large multicentre cohort in South Africa.HIV-1 transgenic rats display alterations in immunophenotype and cellular responses associated with aging.High IP-10 levels decrease T cell function in HIV-1-infected individuals on ARTCD28 expression is required after T cell priming for helper T cell responses and protective immunity to infection.Risk of cataract among subjects with acquired immune deficiency syndrome free of ocular opportunistic infections.Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects.Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients.Effect of Extra Virgin Olive Oil on Biomarkers of Inflammation in HIV-Infected Patients: A Randomized, Crossover, Controlled Clinical Trialp16INK4a Expression and Immunologic Aging in Chronic HIV Infection.COPD in HIV-Infected Patients: CD4 Cell Count Highly Correlated.Malignancies, Particularly B-Cell Lymphomas, Are a Frequent Cause of Mortality in Human Immunodeficiency Virus-1 Patients Despite Highly Active Antiretroviral TherapyCD4+/CD8+ ratio, age, and risk of serious noncommunicable diseases in HIV-infected adults on antiretroviral therapyProinflammatory isoforms of IL-32 as novel and robust biomarkers for control failure in HIV-infected slow progressors.A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus.The protease inhibitors and HIV-associated bone loss.Human Immunodeficiency Virus (HIV).Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIVOverall and cause-specific excess mortality in HIV-positive persons compared with the general population: Role of HCV coinfection.Contributions of Nonhuman Primates to Research on Aging.HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation.Bone Loss in HIV Infection.Lung microbiome in human immunodeficiency virus infection.The Initial Months of Antiretroviral Therapy and Its Influence on AGEs, HMGB1, and sRAGE Levels in Asymptomatic HIV-Infected Individuals.Refining Current Scientific Priorities and Identifying New Scientific Gaps in HIV-Related Heart, Lung, Blood, and Sleep Research.Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder.Soluble Levels of Receptor for Advanced Glycation Endproducts (RAGE) and Progression of Atherosclerosis in Individuals Infected with Human Immunodeficiency Virus: ACTG NWCS 332.Mechanisms of liver disease in patients infected with HIV.Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss.Viruses, Aging, and Chronic Lung Disease.A time-motion study of cardiovascular disease risk factor screening integrated into HIV clinic visits in Swaziland.
P2860
Q26774666-D42264CF-2728-4D06-B196-115A336447B9Q28084981-B8A0CC41-1D7E-4C29-9F22-9F493E8DFB8AQ31066302-F961AEB9-D908-424D-A5C0-1AB257469B7FQ33783987-DAE9D1A0-CCC7-4500-9D5E-422950720BFFQ34050958-05EE710D-3230-448C-9F2F-385E838F16BCQ34484092-BAEE5A8C-0A4C-4BB6-A392-13CE4FCE9803Q34561705-44A9BA7D-40F9-4DCB-A9A4-D4896AAFCF63Q34613114-5555A3D8-6FDB-480B-B112-34BF00E422BBQ34823231-51E11299-A540-4DCE-81A0-A170D570361CQ35708716-E91D7964-B2A2-4CCF-B82B-66B3A31708C0Q35935297-13B318B3-FE07-4FDB-8F4E-B3CA55464182Q35980476-83C81388-EBEC-44F2-9FCE-BCC0C37789B7Q36197327-0D900842-2F1E-4E60-859B-C298AC785330Q36240320-3CF887F1-2056-4635-B6E3-D5301E8794D1Q36241641-2245AE0F-8482-41C5-8B9D-3B3AB7AD6A0BQ36671999-8423314B-9859-4566-8EB9-9391E5F960DAQ36687921-5DA8C8B8-4563-4843-9722-D388C7833C4FQ36692572-5F21E8C2-D3F4-41CC-BC74-ED700317C5D7Q36818259-493DEB68-DDD2-4213-9CE8-A0EF60E858AFQ37045832-EB806409-BB25-419F-84CB-FE91754915EFQ37222229-A7DF552C-7D5F-4656-8130-456DADF731D4Q37256940-CAD7DCD7-6029-4F85-BF7C-512B9BED8FB0Q37265056-C255490D-D419-46B8-BF4B-2AD508AD960AQ37683137-9C01962C-ED9E-4D46-A82F-E2D6DAB68462Q38835028-88EE65CA-6CCC-4892-9FEA-85209EF29D5EQ38920108-24EC0E29-B5AD-4728-84A0-4F96AC17787EQ39512269-E4FE2CED-0086-4217-B541-75EA85B8FF1EQ40191380-357A81B3-6C59-402C-B7FD-37864B51EB97Q40519915-38404E61-AD50-43CA-989B-ABE4D8A6C7ACQ40662634-B2161514-0B48-47A1-A8C0-DC6750E987C9Q45072392-06542303-FFD5-498F-8ABB-4F5E51EB8061Q47194100-DD3053C1-CA41-4EBE-8F65-D1388DC0DE38Q51766410-1A9D2131-7548-4BD0-A316-816808F325D9Q55092353-8C229E51-0CC4-456E-8DAD-C48BCCB5153D
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aging, inflammation, and HIV infection
@ast
Aging, inflammation, and HIV infection
@en
Aging, inflammation, and HIV infection
@nl
type
label
Aging, inflammation, and HIV infection
@ast
Aging, inflammation, and HIV infection
@en
Aging, inflammation, and HIV infection
@nl
prefLabel
Aging, inflammation, and HIV infection
@ast
Aging, inflammation, and HIV infection
@en
Aging, inflammation, and HIV infection
@nl
P3181
P1476
Aging, inflammation, and HIV infection
@en
P2093
Judith A Aberg
P304
P3181
P407
P577
2012-08-01T00:00:00Z